Colgate-Palmolive Stock Forecast, Price & News

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CL stock has increased by 9.1% and is now trading at $75.14.
View which stocks have been most impacted by COVID-19.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Colgate-Palmolive.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) announced its earnings results on Friday, July, 31st. The company reported $0.74 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.69 by $0.05. The business had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a return on equity of 559.34% and a net margin of 16.13%. Colgate-Palmolive's revenue was up .8% compared to the same quarter last year. During the same period last year, the business earned $0.72 earnings per share.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive declared a quarterly dividend on Thursday, September 10th. Investors of record on Friday, October 23rd will be given a dividend of $0.44 per share on Monday, November 16th. This represents a $1.76 dividend on an annualized basis and a yield of 2.34%. The ex-dividend date of this dividend is Thursday, October 22nd.
View Colgate-Palmolive's dividend history.

12 brokers have issued 12-month price targets for Colgate-Palmolive's stock. Their forecasts range from $58.00 to $88.00. On average, they anticipate Colgate-Palmolive's share price to reach $75.82 in the next twelve months. This suggests a possible upside of 0.9% from the stock's current price.
View analysts' price targets for Colgate-Palmolive.

Colgate-Palmolive saw a decrease in short interest in August. As of August 14th, there was short interest totaling 9,410,000 shares, a decrease of 12.5% from the July 30th total of 10,760,000 shares. Based on an average daily volume of 3,620,000 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.1% of the shares of the company are sold short.
View Colgate-Palmolive's Short Interest.

Some companies that are related to Colgate-Palmolive include Procter & Gamble (PG), Kimberly Clark (KMB), Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AbbVie (ABBV), AT&T (T), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Walt Disney (DIS), Intel (INTC) and Mcdonald's (MCD).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.00%), BlackRock Inc. (6.57%), Bank of New York Mellon Corp (2.09%), First Eagle Investment Management LLC (1.46%), Charles Schwab Investment Management Inc. (0.84%) and Nuveen Asset Management LLC (0.74%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Noel R Wallace, Patricia Verduin, Philip G Shotts, Prabha Parameswaran and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., FIL Ltd, FMR LLC, Nuveen Asset Management LLC, AQR Capital Management LLC, Toronto Dominion Bank, and AJO LP. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Helene D Gayle, Ian M Cook, Jennifer Daniels, John J Huston, John W Kooyman, Michael B Polk, Noel R Wallace, Patricia Verduin, and Philip G Shotts.
View insider buying and selling activity for Colgate-Palmolive.

CL stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, M&G Investment Management Ltd., GUARDCAP ASSET MANAGEMENT Ltd, Conning Inc., Sarasin & Partners LLP, Glenmede Trust Co. NA, CIBC Asset Management Inc, and Prio Wealth Limited Partnership.
View insider buying and selling activity for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CL stock can currently be purchased for approximately $75.14.

Colgate-Palmolive has a market capitalization of $64.43 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis. Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]